Epigenetics and microRNAs in preeclampsia.

First principles of Hamiltonian medicine. Philos Trans R Soc Lond B Biol Sci (2014) 0.83

Genome-scale hypomethylation in the cord blood DNAs associated with early onset preeclampsia. Clin Epigenetics (2015) 0.82

Genome-wide hypermethylation coupled with promoter hypomethylation in the chorioamniotic membranes of early onset pre-eclampsia. Mol Hum Reprod (2014) 0.82

Pregnancy Complications and Later Development of Hypertension. Curr Cardiovasc Risk Rep (2013) 0.81

Associations of blood pressure in pregnancy with offspring blood pressure trajectories during childhood and adolescence: findings from a prospective study. J Am Heart Assoc (2015) 0.81

Pathogenesis and promising non-invasive markers for preeclampsia. Obstet Gynecol Sci (2013) 0.80

The imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsia. Iran J Reprod Med (2015) 0.79

Genome-Wide Mapping of 5mC and 5hmC Identified Differentially Modified Genomic Regions in Late-Onset Severe Preeclampsia: A Pilot Study. PLoS One (2015) 0.76

Potential role of epigenetic mechanisms in regulation of trophoblast differentiation, migration, and invasion in the human placenta. Cell Adh Migr (2016) 0.75

Role of microRNAs in translation regulation and cancer. World J Biol Chem (2017) 0.75

High-throughput deep screening and identification of four peripheral leucocyte microRNAs as novel potential combination biomarkers for preeclampsia. J Perinatol (2015) 0.75

Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med (2004) 14.00

Pre-eclampsia. Lancet (2005) 10.41

Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell (2006) 8.46

Latest advances in understanding preeclampsia. Science (2005) 8.11

Pre-eclampsia. Lancet (2010) 7.46

Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med (2006) 7.06

MicroRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues. Genome Res (2004) 6.98

Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med (2006) 6.21

Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ (2005) 5.96

Prenatal sex determination by DNA amplification from maternal peripheral blood. Lancet (1989) 4.42

Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Mol Cell (2009) 3.68

Endovascular trophoblast invasion: implications for the pathogenesis of intrauterine growth retardation and preeclampsia. Biol Reprod (2003) 3.43

Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem (2003) 3.36

Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension. Circ Res (2007) 3.28

A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med (2003) 3.20

A study of angiotensin II pressor response throughout primigravid pregnancy. J Clin Invest (1973) 3.08

Early nutrition, epigenetic changes at transposons and imprinted genes, and enhanced susceptibility to adult chronic diseases. Nutrition (2004) 3.08

An NF-kappaB-sensitive micro RNA-146a-mediated inflammatory circuit in Alzheimer disease and in stressed human brain cells. J Biol Chem (2008) 2.84

Distinct subsets of microRNAs are expressed differentially in the human placentas of patients with preeclampsia. Am J Obstet Gynecol (2007) 2.78

Pathogenesis of preeclampsia. Annu Rev Pathol (2010) 2.66

Epigenetic regulation of mammalian genomic imprinting. Curr Opin Genet Dev (2004) 2.58

Hypoxia-inducible factor-1 mediates the biological effects of oxygen on human trophoblast differentiation through TGFbeta(3) J Clin Invest (2000) 2.57

Epigenetics and microRNAs. Pediatr Res (2007) 2.52

AngiomiRs--key regulators of angiogenesis. Curr Opin Genet Dev (2009) 2.40

Animal models of human placentation--a review. Placenta (2006) 2.28

Genomic imprinting mechanisms in mammals. Mutat Res (2008) 2.28

Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia. Clin Chem (1999) 2.26

Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nat Genet (1995) 2.24

Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15. Proc Natl Acad Sci U S A (1996) 2.17

Dysregulation of the circulating and tissue-based renin-angiotensin system in preeclampsia. Hypertension (2007) 2.17

Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol (2006) 2.15

Decreased placental methylation at the H19/IGF2 imprinting control region is associated with normotensive intrauterine growth restriction but not preeclampsia. Placenta (2010) 2.09

Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease. J Cell Mol Med (2012) 1.99

Molecular evidence of placental hypoxia in preeclampsia. J Clin Endocrinol Metab (2005) 1.98

Epigenetics, DNA methylation, and chromatin modifying drugs. Annu Rev Pharmacol Toxicol (2009) 1.97

Pre-eclampsia: pathophysiology, diagnosis, and management. Vasc Health Risk Manag (2011) 1.86

Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc Natl Acad Sci U S A (2005) 1.81

Brain renin-angiotensin system: fetal epigenetic programming by maternal protein restriction during pregnancy. Reprod Sci (2009) 1.79

Targeted disruption of p185/Cul7 gene results in abnormal vascular morphogenesis. Proc Natl Acad Sci U S A (2003) 1.78

Epigenetics in the placenta. Am J Reprod Immunol (2009) 1.77

Differential expression profile of microRNAs in human placentas from preeclamptic pregnancies vs normal pregnancies. Am J Obstet Gynecol (2009) 1.72

The H19 gene: regulation and function of a non-coding RNA. Cytogenet Genome Res (2006) 1.71

Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21. Clin Chem (1999) 1.65

Epigenetics and the placenta. Hum Reprod Update (2010) 1.59

Morphological changes of the spiral arteries in the placental bed in relation to pre-eclampsia and fetal growth retardation. Br J Obstet Gynaecol (1981) 1.56

DNA methylation profiling of human placentas reveals promoter hypomethylation of multiple genes in early-onset preeclampsia. Eur J Hum Genet (2010) 1.55

Characterization of an NF-kappaB-regulated, miRNA-146a-mediated down-regulation of complement factor H (CFH) in metal-sulfate-stressed human brain cells. J Inorg Biochem (2009) 1.55

Mutations in complement regulatory proteins predispose to preeclampsia: a genetic analysis of the PROMISSE cohort. PLoS Med (2011) 1.52

Placental microRNA expression in pregnancies complicated by preeclampsia. Am J Obstet Gynecol (2010) 1.52

Folic acid supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol (2008) 1.50

Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation. Mol Cell Biol (2002) 1.50

Sites of differential DNA methylation between placenta and peripheral blood: molecular markers for noninvasive prenatal diagnosis of aneuploidies. Am J Pathol (2009) 1.46

Cullins in human intra-uterine growth restriction: expressional and epigenetic alterations. Placenta (2009) 1.46

Evidence for the functional activity of hypoxia-inducible transcription factors overexpressed in preeclamptic placentae. Placenta (2004) 1.46

Expression profile of microRNAs and mRNAs in human placentas from pregnancies complicated by preeclampsia and preterm labor. Reprod Sci (2010) 1.45

Developmental biology of the placenta and the origins of placental insufficiency. Semin Fetal Neonatal Med (2004) 1.39

Vascular mechanisms of increased arterial pressure in preeclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol (2002) 1.36

The genetics of pre-eclampsia and other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol (2011) 1.31

Differential expression of microRNAs in the placentae of Chinese patients with severe pre-eclampsia. Clin Chem Lab Med (2009) 1.31

The impact of 5-azacytidine on placental weight, glycoprotein pattern and proliferating cell nuclear antigen expression in rat placenta. Placenta (2007) 1.28

Epigenetic regulation of human trophoblastic cell migration and invasion. Endocrinology (2006) 1.27

Investigation of maternal effects, maternal-fetal interactions and parent-of-origin effects (imprinting), using mothers and their offspring. Genet Epidemiol (2011) 1.26

Chromatin mechanisms in genomic imprinting. Mamm Genome (2009) 1.26

Human cytotrophoblasts promote endothelial survival and vascular remodeling through secretion of Ang2, PlGF, and VEGF-C. Dev Biol (2003) 1.24

Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. J Hepatol (2011) 1.20

Global DNA methylation patterns in placenta and its association with maternal hypertension in pre-eclampsia. DNA Cell Biol (2010) 1.17

Maternal plasma fetal DNA as a marker for preterm labour. Lancet (1998) 1.16

Oxygen-regulated erythropoietin gene expression is dependent on a CpG methylation-free hypoxia-inducible factor-1 DNA-binding site. Eur J Biochem (1998) 1.14

MicroRNA-155 contributes to preeclampsia by down-regulating CYR61. Am J Obstet Gynecol (2010) 1.14

Fetal DNA in maternal plasma is elevated in pregnancies with aneuploid fetuses. Prenat Diagn (2000) 1.14

Fetal growth restriction. Semin Perinatol (2008) 1.13

Abnormal placentation, angiogenic factors, and the pathogenesis of preeclampsia. Obstet Gynecol Clin North Am (2010) 1.11

Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice. Mol Hum Reprod (2002) 1.11

Surgically obtained sperm, and risk of gestational hypertension and pre-eclampsia. Lancet (2002) 1.11

Pre-eclampsia: connecting angiogenic and metabolic pathways. Trends Endocrinol Metab (2010) 1.10

Genetic and epigenetic factors contribute to the onset of preeclampsia. Mol Cell Endocrinol (2007) 1.09

Epigenetic modifications at the human growth hormone locus predict distinct roles for histone acetylation and methylation in placental gene activation. Mol Endocrinol (2004) 1.08

Endocrine disruptors, environmental oxygen, epigenetics and pregnancy. Front Biosci (Elite Ed) (2011) 1.07

Abnormal placentation and the syndrome of preeclampsia. Semin Nephrol (2004) 1.06

Oxygen and placental vascular development. Adv Exp Med Biol (1999) 1.05

microRNA-155 regulates angiotensin II type 1 receptor expression in umbilical vein endothelial cells from severely pre-eclamptic pregnant women. Int J Mol Med (2011) 1.04

Expressional and epigenetic alterations of placental serine protease inhibitors: SERPINA3 is a potential marker of preeclampsia. Hypertension (2006) 1.02

The expression of VEGF receptor genes is concurrently influenced by epigenetic gene silencing of the genes and VEGF activation. Epigenetics (2009) 1.01

MicroRNA-155 is involved in the remodelling of human-trophoblast-derived HTR-8/SVneo cells induced by lipopolysaccharides. Hum Reprod (2011) 1.01

Hypoxia-induced erythropoietin expression in human neuroblastoma requires a methylation free HIF-1 binding site. J Cell Biochem (2004) 1.00

Histone deacetylase 3 binds to and regulates the GCMa transcription factor. Nucleic Acids Res (2006) 1.00

Current understandings of the molecular genetics of gestational trophoblastic diseases. Placenta (2002) 1.00

Expression profile of trophoblast invasion-associated genes in the pre-eclamptic placenta. Br J Biomed Sci (2003) 0.99

The H19 gene imprinting in normal pregnancy and pre-eclampsia. Placenta (2009) 0.97

Decidualized endometrial stromal cell derived factors promote trophoblast invasion. Fertil Steril (2010) 0.96

The epigenomic interface between genome and environment in common complex diseases. Brief Funct Genomics (2010) 0.96

Genomic imprinting, development and disease--is pre-eclampsia caused by a maternally imprinted gene? Reprod Fertil Dev (1998) 0.96

Imprinted genes and mother-offspring interactions. Early Hum Dev (2004) 0.95

Epigenetic studies in human diseases. Folia Biol (Praha) (2010) 0.95

Cell-free nucleic acids as potential markers for preeclampsia. Placenta (2011) 0.95

miRNA expression profiling in formalin-fixed and paraffin-embedded placental tissue samples from pregnancies with severe preeclampsia. J Perinat Med (2011) 0.94

Circulatory fetal and maternal DNA in pregnancies at risk and those affected by preeclampsia. Ann N Y Acad Sci (2001) 0.93

Transcription of the H19 gene in differentiating cytotrophoblasts from human placenta. Mol Reprod Dev (1992) 0.93

Preeclampsia and the Anti-Angiogenic State. Pregnancy Hypertens (2011) 0.92

Quantitative aberrations of hypermethylated RASSF1A gene sequences in maternal plasma in pre-eclampsia. Prenat Diagn (2007) 0.92

Maternal high-fat diet triggers lipotoxicity in the fetal livers of nonhuman primates. J Clin Invest (2009) 3.10

Maternal obesity and fetal metabolic programming: a fertile epigenetic soil. Am J Physiol Regul Integr Comp Physiol (2010) 2.28

TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes (2002) 2.20

Hepatitis C virus infection: molecular pathways to metabolic syndrome. Hepatology (2008) 2.10

Fatty liver is associated with reduced SIRT3 activity and mitochondrial protein hyperacetylation. Biochem J (2011) 1.96

Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care (2007) 1.70

CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis. Hepatology (2007) 1.49

C/EBPalpha regulates human adiponectin gene transcription through an intronic enhancer. Diabetes (2005) 1.48

Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues. Diabetes (2008) 1.41

Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice. J Biol Chem (2002) 1.38

Growth hormone regulation of p85alpha expression and phosphoinositide 3-kinase activity in adipose tissue: mechanism for growth hormone-mediated insulin resistance. Diabetes (2007) 1.36

Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy. Am J Physiol Endocrinol Metab (2002) 1.35

CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr(db/db) mice. J Biol Chem (2007) 1.35

De novo generation of white adipocytes from the myeloid lineage via mesenchymal intermediates is age, adipose depot, and gender specific. Proc Natl Acad Sci U S A (2010) 1.35

Intrauterine growth restriction increases fetal hepatic gluconeogenic capacity and reduces messenger ribonucleic acid translation initiation and nutrient sensing in fetal liver and skeletal muscle. Endocrinology (2009) 1.32

C/EBP transcription factors regulate SREBP1c gene expression during adipogenesis. Biochem J (2009) 1.28

Human placental growth hormone increases expression of the p85 regulatory unit of phosphatidylinositol 3-kinase and triggers severe insulin resistance in skeletal muscle. Endocrinology (2003) 1.26

Patterns of glycemia in normal pregnancy: should the current therapeutic targets be challenged? Diabetes Care (2011) 1.24

Chronic late-gestation hypoglycemia upregulates hepatic PEPCK associated with increased PGC1alpha mRNA and phosphorylated CREB in fetal sheep. Am J Physiol Endocrinol Metab (2007) 1.23

Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. J Biol Chem (2005) 1.22

Reversal of insulin resistance postpartum is linked to enhanced skeletal muscle insulin signaling. J Clin Endocrinol Metab (2004) 1.15

Intrahepatic fat is increased in the neonatal offspring of obese women with gestational diabetes. J Pediatr (2012) 1.14

Maternal high fat diet is associated with decreased plasma n-3 fatty acids and fetal hepatic apoptosis in nonhuman primates. PLoS One (2011) 1.13

A maternal high-fat diet modulates fetal SIRT1 histone and protein deacetylase activity in nonhuman primates. FASEB J (2012) 1.11

Human placental growth hormone causes severe insulin resistance in transgenic mice. Am J Obstet Gynecol (2002) 1.11

CCAAT/enhancer-binding protein β (C/EBPβ) expression regulates dietary-induced inflammation in macrophages and adipose tissue in mice. J Biol Chem (2012) 1.07

Sequential regulation of diacylglycerol acyltransferase 2 expression by CAAT/enhancer-binding protein beta (C/EBPbeta) and C/EBPalpha during adipogenesis. J Biol Chem (2007) 1.06

Phosphatidylinositol 3-kinase redistribution is associated with skeletal muscle insulin resistance in gestational diabetes mellitus. Diabetes (2002) 1.02

Acute supplementation of amino acids increases net protein accretion in IUGR fetal sheep. Am J Physiol Endocrinol Metab (2012) 1.01

Chronic hyperglycemia enhances PEPCK gene expression and hepatocellular glucose production via elevated liver activating protein/liver inhibitory protein ratio. Diabetes (2005) 1.01

Transgenic increase in N-3/n-6 Fatty Acid ratio reduces maternal obesity-associated inflammation and limits adverse developmental programming in mice. PLoS One (2013) 1.01

Insulin is required for amino acid stimulation of dual pathways for translational control in skeletal muscle in the late-gestation ovine fetus. Am J Physiol Endocrinol Metab (2008) 1.00

Reduced mitochondrial function in obesity-associated fatty liver: SIRT3 takes on the fat. Aging (Albany NY) (2011) 0.99

Effect of spontaneous gestational diabetes on fetal and postnatal hepatic insulin resistance in Lepr(db/+) mice. Pediatr Res (2003) 0.98

Regulation of cyclin D1 and Wnt10b gene expression by cAMP-responsive element-binding protein during early adipogenesis involves differential promoter methylation. J Biol Chem (2008) 0.97

Increased hepatic glucose production in fetal sheep with intrauterine growth restriction is not suppressed by insulin. Diabetes (2012) 0.96

Prolactin, progesterone, and dexamethasone coordinately and adversely regulate glucokinase and cAMP/PDE cascades in MIN6 beta-cells. Am J Physiol Endocrinol Metab (2003) 0.94

Fenofibrate and PBA prevent fatty acid-induced loss of adiponectin receptor and pAMPK in human hepatoma cells and in hepatitis C virus-induced steatosis. J Lipid Res (2009) 0.93

A higher-complex carbohydrate diet in gestational diabetes mellitus achieves glucose targets and lowers postprandial lipids: a randomized crossover study. Diabetes Care (2014) 0.93

Attenuated Pik3r1 expression prevents insulin resistance and adipose tissue macrophage accumulation in diet-induced obese mice. Diabetes (2012) 0.93

Regulation of pyruvate dehydrogenase kinase 4 (PDK4) by CCAAT/enhancer-binding protein beta (C/EBPbeta). J Biol Chem (2011) 0.91

Effects of acute hyperinsulinemia on insulin signal transduction and glucose transporters in ovine fetal skeletal muscle. Am J Physiol Regul Integr Comp Physiol (2004) 0.91

Preconception maternal nutrition: a multi-site randomized controlled trial. BMC Pregnancy Childbirth (2014) 0.90

Skeletal muscle MnSOD, mitochondrial complex II, and SIRT3 enzyme activities are decreased in maternal obesity during human pregnancy and gestational diabetes mellitus. J Clin Endocrinol Metab (2013) 0.90

Lactation and neonatal nutrition: defining and refining the critical questions. J Mammary Gland Biol Neoplasia (2012) 0.89

Developmental changes in ovine myocardial glucose transporters and insulin signaling following hyperthermia-induced intrauterine fetal growth restriction. Exp Biol Med (Maywood) (2006) 0.88

Chronically increased S6K1 is associated with impaired IRS1 signaling in skeletal muscle of GDM women with impaired glucose tolerance postpartum. J Clin Endocrinol Metab (2011) 0.88

C/EBPβ is AMP kinase sensitive and up-regulates PEPCK in response to ER stress in hepatoma cells. Mol Cell Endocrinol (2010) 0.87

Strategies in the nutritional management of gestational diabetes. Clin Obstet Gynecol (2013) 0.87

Testing the fuel-mediated hypothesis: maternal insulin resistance and glucose mediate the association between maternal and neonatal adiposity, the Healthy Start study. Diabetologia (2015) 0.87

Perinatal exposure to a high-fat diet is associated with reduced hepatic sympathetic innervation in one-year old male Japanese macaques. PLoS One (2012) 0.87

Maternal fuels and metabolic measures during pregnancy and neonatal body composition: the healthy start study. J Clin Endocrinol Metab (2015) 0.84

Increased phosphoenolpyruvate carboxykinase gene expression and steatosis during hepatitis C virus subgenome replication: role of nonstructural component 5A and CCAAT/enhancer-binding protein β. J Biol Chem (2012) 0.82

Therapeutic actions of an insulin receptor activator and a novel peroxisome proliferator-activated receptor gamma agonist in the spontaneously hypertensive obese rat model of metabolic syndrome X. J Pharmacol Exp Ther (2005) 0.80

Sirtuin 3: A major control point for obesity-related metabolic diseases? Drug Discov Today Dis Mech (2013) 0.80

Developmental programming of pediatric nonalcoholic fatty liver disease: redefining the"first hit". Clin Obstet Gynecol (2013) 0.78

Obesity: childhood obesity--methylate now, pay later? Nat Rev Endocrinol (2011) 0.77

CCAAT/enhancer binding protein β deletion increases mitochondrial function and protects mice from LXR-induced hepatic steatosis. Biochem Biophys Res Commun (2012) 0.76

Preferences for heat, cold, or contrast in patients with knee osteoarthritis affect treatment response. Clin Interv Aging (2010) 0.75

Comment on: Rowan et al. Metformin in Gestational diabetes: The Offspring Follow-Up (MiG TOFU): body composition at 2 years of age. Diabetes Care 2011;34:2279-2284. Diabetes Care (2012) 0.75

Correction: Spaceflight Activates Lipotoxic Pathways in Mouse Liver. PLoS One (2016) 0.75

Responses to superficial heating and cooling differ in men and women with knee osteoarthritis. Physiother Theory Pract (2011) 0.75